TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7983993

Group type: EXPERIMENTAL
Intervention: Amphotericin B (0.5 mg/kg infused in 5% dextrose on alternate days for 14 doses)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sodium stibogluconate (20 mg/kg in two divided doses daily for 40 days)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Amphotericin B
Number of subjects: 80
Study: 2596425

Group type: EXPERIMENTAL
Intervention: SR 29001 (0.15 U/kg body wt)
Number of subjects: 12
Study: 1096609

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no prostaglandin E2)
Number of subjects: 30
Study: 31498467

Group type: EXPERIMENTAL
Intervention: 7 days of absolute voice rest
Number of subjects: 30

Group type: COMPARATOR
Intervention: No voice rest (control)
Number of subjects: 30
Study: 31395035

Group type: EXPERIMENTAL
Intervention: Height-for-age Z score (HAZ)
Number of subjects: 178393
Study: 28918534

Group type: EXPERIMENTAL
Intervention: Surgical helmet systems (SHS) without tape at the gown/glove interface
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard surgical gowns (SG)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Surgical helmet systems (SHS) with tape at the gown/glove interface
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Surgical helmet systems (SHS) without tape
Number of subjects: 75
Study: 26405263

Group type: EXPERIMENTAL
Intervention: UPA 30 mg followed by DSG 75 µg per day for 20 days
Number of subjects: 71

Group type: COMPARATOR
Intervention: UPA 30 mg followed by placebo matching DSG for 20 days
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo matching UPA followed by DSG 75 µg per day for 20 days
Number of subjects: 71
Study: 23700090

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) 60,000 U
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) ≥30,000 U
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Baseline EPC levels
Number of subjects: 222
Study: 21786319

Group type: EXPERIMENTAL
Intervention: Diet group
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Diet-Exercise group
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 107
Study: 18586990

Group type: EXPERIMENTAL
Intervention: Evidence-based treatments for depression, anxiety, and conduct problems in children
Number of subjects: 68
Study: 16494662

Group type: EXPERIMENTAL
Intervention: Postmodern ironist concept of research validity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postmodern critique of modernist nursing research
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Writings of poststructuralist philosophers
Number of subjects: 0
Study: 12846095

Group type: EXPERIMENTAL
Intervention: Ligation of all visible veins of the seminal cord
Number of subjects: 418

Group type: COMPARATOR
Intervention: Microsurgical reconstruction by connecting the distal end of the lower epigastric vein
Number of subjects: 418
Study: 10690447

Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC) exercise
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sedentary control group
Number of subjects: 28
Study: 9099449

Group type: EXPERIMENTAL
Intervention: 250 mg Lamisil (terbinafine) once daily for 15 days under fed condition
Number of subjects: 30

Group type: COMPARATOR
Intervention: 250 mg Lamisil (terbinafine) once daily for 15 days under fasted condition
Number of subjects: 30
Study: 7895357

Group type: EXPERIMENTAL
Intervention: Holter monitoring and electrophysiological study
Number of subjects: 226

Group type: COMPARATOR
Intervention: Holter monitoring
Number of subjects: 226

Group type: COMPARATOR
Intervention: Electrophysiological study
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Suppression of both spontaneous and inducible arrhythmias
Number of subjects: 226
Study: 2706190

Group type: EXPERIMENTAL
Intervention: Sodium octanoate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sodium salicylate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 0
Study: 31455425

Group type: EXPERIMENTAL
Intervention: 4 mg intravenous (IV) zoledronic acid (ZA) administered within 24 hours of chemotherapy, repeated every 21 days for 6 cycles.
Number of subjects: 246

Group type: COMPARATOR
Intervention: Standard 6 cycles of neoadjuvant TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy without ZA.
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: 4 mg intravenous (IV) zoledronic acid (ZA) in postmenopausal women.
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: 4 mg intravenous (IV) zoledronic acid (ZA) in premenopausal women.
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Lower serum levels of insulin.
Number of subjects: 246
Study: 28934762

Group type: EXPERIMENTAL
Intervention: 150 min/wk of aerobic exercise (low dose)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 300 min/wk of aerobic exercise (high dose)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Each 60 min/wk increase in exercise
Number of subjects: 39

Group type: COMPARATOR
Intervention: Usual-care control
Number of subjects: 39
Study: 25280197

Group type: EXPERIMENTAL
Intervention: Health Belief Model (HBM) intervention
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Theory of Planned Behavior (TPB) intervention
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 184
Study: 24553356

Group type: EXPERIMENTAL
Intervention: Postemployment advisory support and financial incentives (ERA program)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not eligible for ERA)
Number of subjects: 0
Study: 21237568

Group type: EXPERIMENTAL
Intervention: S(+)‐ketamine (40mg per 70kg) infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 10
Study: 18385980

Group type: EXPERIMENTAL
Intervention: I‐ONE PEMFs treatment (active group)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo treatment (control group)
Number of subjects: 69
Study: 16441988

Group type: EXPERIMENTAL
Intervention: Surgical treatment (incision-curettage)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Intralesional corticosteroid injection
Number of subjects: 141
Study: 12596079

Group type: EXPERIMENTAL
Intervention: Direct stent implantation (DS)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Provisional stenting (PB)
Number of subjects: 250
Study: 11111356

Group type: EXPERIMENTAL
Intervention: Patient-guided counseling (PGC) with written prompt for questions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Written prompt encouraging questions followed by customary verbal counseling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with customary verbal counseling and no prompts
Number of subjects: 0
Study: 9085319

Group type: EXPERIMENTAL
Intervention: Pharmacist recommendations to discontinue intravenous antibiotic therapy
Number of subjects: 102

Group type: COMPARATOR
Intervention: Observation without intervention
Number of subjects: 102
Study: 1490755

Group type: EXPERIMENTAL
Intervention: Oral vitamin E (300 mg/day) for eight weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 2932213

Group type: EXPERIMENTAL
Intervention: Oral high-dose medroxyprogesterone acetate (HD-MPA) 400 mg daily
Number of subjects: 87

Group type: COMPARATOR
Intervention: Mepitiostane (MS) 10 mg daily
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Oral high-dose medroxyprogesterone acetate (HD-MPA)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Mepitiostane (MS)
Number of subjects: 87
Study: 31478240

Group type: EXPERIMENTAL
Intervention: Measurement error correction using external calibration sample
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Measurement error ignored
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Measurement error systematic or differential
Number of subjects: 0
Study: 29474851

Group type: EXPERIMENTAL
Intervention: Active learning (math n=10; spelling n=9)
Number of subjects: 2716

Group type: COMPARATOR
Intervention: Traditional, sedentary academic lessons (n=9)
Number of subjects: 2716

Group type: EXPERIMENTAL
Intervention: Active learning with planned physical activity (PA)
Number of subjects: 2716

Group type: COMPARATOR
Intervention: Greater dose of PA in control schools
Number of subjects: 2716
Study: 27185509

Group type: EXPERIMENTAL
Intervention: Telekit system
Number of subjects: 60
Study: 25509737

Group type: EXPERIMENTAL
Intervention: Acupuncture at Sanyinjiao (SP 6), Hegu (LI 4), Qihai (CV 6), Guanyuan (CV 4), started 2 hours after operation, once a day for five days
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional treatment after cesarean section
Number of subjects: 70
Study: 21811855

Group type: EXPERIMENTAL
Intervention: Flexion group (knee flexed to 30°)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Extension group (knee extended fully)
Number of subjects: 110
Study: 20220185

Group type: EXPERIMENTAL
Intervention: Eprotirome 25 microg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eprotirome 50 microg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eprotirome 100 microg per day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18813048

Group type: EXPERIMENTAL
Intervention: High-pressure injection (> 20 psi)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Low-pressure injection (< 15 psi)
Number of subjects: 80
Study: 16041965

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program (CRP) for 12 weeks, 3 times a week
Number of subjects: 203

Group type: COMPARATOR
Intervention: Standard cardiology follow-up
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program (CRP)
Number of subjects: 203
Study: 11804979

Group type: EXPERIMENTAL
Intervention: Lytic monotherapy
Number of subjects: 221

Group type: COMPARATOR
Intervention: Lytic plus rhuMAb CD18
Number of subjects: 221
Study: 10029609

Group type: EXPERIMENTAL
Intervention: Mesalamine tablets, 4 g
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Mesalamine microgranular preparation, 4 g
Number of subjects: 94

Group type: COMPARATOR
Intervention: 6‐methylprednisolone, 40 mg
Number of subjects: 94
Study: 7548602

Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clindamycin plus tobramycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clindamycin plus gentamicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imipenem and cilastatin
Number of subjects: 0
Study: 2208536

Group type: EXPERIMENTAL
Intervention: Ranitidine + Metoclopramide + Sodium Citrate
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Sodium Citrate
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 196

Group type: COMPARATOR
Intervention: Ranitidine alone
Number of subjects: 196
Study: 7127178

Group type: EXPERIMENTAL
Intervention: Moderate hypotension during spinal fusion surgery
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Monitoring of somatosensory evoked potentials
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Reversal of hypotension and haemodilution when evoked potentials altered
Number of subjects: 24
Study: 31018616

Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 137
Study: 29017578

Group type: EXPERIMENTAL
Intervention: Family Integrated Care (FICare)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 181
Study: 25106663

Group type: EXPERIMENTAL
Intervention: Filorexant 10 mg nightly
Number of subjects: 235

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235
Study: 24366758

Group type: EXPERIMENTAL
Intervention: Docetaxel plus S-1
Number of subjects: 639

Group type: COMPARATOR
Intervention: S-1 alone
Number of subjects: 639
Study: 22956052

Group type: EXPERIMENTAL
Intervention: Statin group (rosuvastatin 10 mg per day for 6 months)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70

Group type: COMPARATOR
Intervention: Statin group vs Control group
Number of subjects: 70
Study: 19747406

Group type: EXPERIMENTAL
Intervention: PDR ICG one hour after admission to the ICU
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Late postoperative ASAT measurement
Number of subjects: 60

Group type: COMPARATOR
Intervention: PDR ICG, ASAT, and alpha-GST measurements
Number of subjects: 60
Study: 17261626

Group type: EXPERIMENTAL
Intervention: Brecanavir (BCV) 50 to 600 mg with 100 mg ritonavir (RTV) every 12 hours or every 24 hours for 15 days
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Brecanavir (BCV) 800 mg every 12 hours for 15 days
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Brecanavir (BCV) with RTV 100 mg
Number of subjects: 68
Study: 15578510

Group type: EXPERIMENTAL
Intervention: Peginterferon alfa‐2a 180 mug/wk plus ribavirin 800 mg/day for 24 weeks
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Peginterferon alfa‐2a 180 mug/wk plus ribavirin 800 mg/day for 48 weeks
Number of subjects: 491

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Peginterferon alfa‐2a plus ribavirin for 24 weeks in patients with HCV genotype 1
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Peginterferon alfa‐2a plus ribavirin for 48 weeks in patients with HCV genotype 1
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Peginterferon alfa‐2a plus ribavirin for 24 weeks in patients with HCV genotypes 2 or 3
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Peginterferon alfa‐2a plus ribavirin for 48 weeks in patients with HCV genotypes 2 or 3
Number of subjects: 491
Study: 11553111

Group type: COMPARATOR
Intervention: 0.376% sodium fluoride (1700 ppm fluoride ion)
Number of subjects: 5439

Group type: COMPARATOR
Intervention: 0.486% sodium fluoride (2200 ppm fluoride ion)
Number of subjects: 5439

Group type: COMPARATOR
Intervention: 0.619% sodium fluoride (2800 ppm fluoride ion)
Number of subjects: 5439

Group type: EXPERIMENTAL
Intervention: 0.243% sodium fluoride (1100 ppm fluoride ion)
Number of subjects: 5439
Study: 9474236

Group type: EXPERIMENTAL
Intervention: TICE® BCG (six weekly intravesical instillations)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 30
Study: 7892398

Group type: EXPERIMENTAL
Intervention: Tridimensional Personality Questionnaire
Number of subjects: 0
Study: 3048951

Group type: EXPERIMENTAL
Intervention: RAES (Ruscus aculeatus extract 16.5 mg, hesperidin 75 mg, ascorbic acid 50 mg), 2 capsules, 3 times/day for 2 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 30779849

Group type: EXPERIMENTAL
Intervention: ACEs-Intervention (ACEs-I)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Activators
Number of subjects: 54

Group type: COMPARATOR
Intervention: ACEs-Control (ACEs-C)
Number of subjects: 54
Study: 28866110

Group type: EXPERIMENTAL
Intervention: Bikram yoga (3-5 classes per week for 16 weeks)
Number of subjects: 63
Study: 27664367

Group type: EXPERIMENTAL
Intervention: Interpretation Bias Modification (IBM) training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo Control (PC)
Number of subjects: 40
Study: 25687152

Group type: EXPERIMENTAL
Intervention: School-based sleep education program
Number of subjects: 3713

Group type: COMPARATOR
Intervention: Control group (no sleep program)
Number of subjects: 3713
Study: 23299384

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (2 fish oil capsules per day for 6 months)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo (2 olive oil capsules per day for 6 months)
Number of subjects: 126
Study: 19760131

Group type: EXPERIMENTAL
Intervention: Dorsal dartos flap (Group 1, mean age 22.3 years)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Ventral dartos flap (Group 2, mean age 21.1 years)
Number of subjects: 42
Study: 19057251

Group type: EXPERIMENTAL
Intervention: Double-door cervical laminoplasty using suture anchors
Number of subjects: 145
Study: 17140047

Group type: EXPERIMENTAL
Intervention: 100 mg of rectal indomethacin administered 2 hours prior to ERCP
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo (glycerine suppository)
Number of subjects: 117
Study: 14614780

Group type: EXPERIMENTAL
Intervention: Niacin 500 mg
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 10674604

Group type: EXPERIMENTAL
Intervention: Quadruple anti-helicobacter therapy
Number of subjects: 99

Group type: COMPARATOR
Intervention: Omeprazole alone
Number of subjects: 99
Study: 9058216

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MPS), 1 g IV before CPB
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Aprotinin-full-dose protocol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study: 8362629

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygenation
Number of subjects: 51
Study: 2946016

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (n = 17)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: TENS (low intensity transcutaneous nerve stimulation, n = 18)
Number of subjects: 54

Group type: COMPARATOR
Intervention: TENS dead-battery (placebo, n = 18)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Overall treatment effect (all groups)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Visual Analogue Scale measure of average pain (Electroacupuncture group)
Number of subjects: 54
Study: 31360884

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 4830

Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 4830
Study: 26669813

Group type: EXPERIMENTAL
Intervention: Healthy Weight (HW) intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 0
Study: 25017182

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20‐mg tablet
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Olmesartan 40‐mg tablet
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Coadministration of rosuvastatin 20‐mg tablet and olmesartan 40‐mg tablet
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (Mono-administration of rosuvastatin or olmesartan)
Number of subjects: 36
Study: 22251033

Group type: EXPERIMENTAL
Intervention: SMS text message reminders
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control group (no SMS reminders)
Number of subjects: 206
Study: 19875337

Group type: COMPARATOR
Intervention: Radical radiotherapy alone (n=233)
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Radiotherapy with two courses of chemotherapy given simultaneously (SIM alone; n=166)
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Radiotherapy with chemotherapy given after treatment (SUB alone; n=160)
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Both concurrent and maintenance chemotherapy (SIM+SUB; n=154)
Number of subjects: 966

Group type: COMPARATOR
Intervention: Radiotherapy alone (for patients who had undergone surgery; n=135)
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: Radiotherapy with chemotherapy (SIM alone; n=118)
Number of subjects: 966
Study: 19134067

Group type: EXPERIMENTAL
Intervention: Educational programme designed to account for training needs and learning styles
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standardised educational programme
Number of subjects: 0
Study: 15672051

Group type: EXPERIMENTAL
Intervention: Intragastric balloon treatment
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham treatment followed by balloon treatment
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham/balloon treated group
Number of subjects: 43

Group type: COMPARATOR
Intervention: Balloon/balloon treated group
Number of subjects: 43
Study: 12737679

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS)
Number of subjects: 0
Study: 10464894

Group type: EXPERIMENTAL
Intervention: Intensive patient education and supervision for self-management
Number of subjects: 162

Group type: COMPARATOR
Intervention: Conventional education
Number of subjects: 162
Study: 8934371

Group type: EXPERIMENTAL
Intervention: Nifedipine monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nifedipine in hypertension studies
Number of subjects: 0
Study: 1922667

Group type: EXPERIMENTAL
Intervention: Nimodipine (Nimotop)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not given Nimodipine)
Number of subjects: 50
Study: 6225808

Group type: EXPERIMENTAL
Intervention: 1 g of aztreonam
Number of subjects: 112

Group type: COMPARATOR
Intervention: 2 g of spectinomycin
Number of subjects: 112
Study: 31837710

Group type: EXPERIMENTAL
Intervention: Doming test using a custom doming dynamometer (standing)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Toe flexion tests using a custom toe flexion dynamometer (seated)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pressure mat tests (standing)
Number of subjects: 40
Study: 30899949

Group type: EXPERIMENTAL
Intervention: warm gutta‐percha filling technique + iRoot SP
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: warm gutta‐percha filling technique + AH plus
Number of subjects: 95

Group type: COMPARATOR
Intervention: warm gutta‐percha filling technique + Vitapex
Number of subjects: 95
Study: 26555827

Group type: EXPERIMENTAL
Intervention: Brace treatment
Number of subjects: 319

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Brace treatment and Observation (crossover patients)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Brace treatment and Observation (patients with Cobb angles ≥ 40 degrees)
Number of subjects: 319
Study: 24783988

Group type: EXPERIMENTAL
Intervention: Dual therapy with lopinavir 400 mg and ritonavir 100 mg plus lamivudine 150 mg, both twice daily
Number of subjects: 426

Group type: COMPARATOR
Intervention: Triple therapy with lopinavir 400 mg and ritonavir 100 mg twice daily plus lamivudine or emtricitabine and another NRTI
Number of subjects: 426

Group type: COMPARATOR
Intervention: Triple therapy
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Dual therapy
Number of subjects: 426
Study: 22178482

Group type: EXPERIMENTAL
Intervention: Alvimopan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonusers (Control)
Number of subjects: 0
Study: 19643627

Group type: EXPERIMENTAL
Intervention: Milking of chest tubes
Number of subjects: 145

Group type: COMPARATOR
Intervention: Observation of chest tubes without manipulation
Number of subjects: 145